U S Physical Therapy Inc (USPH) stock
Close on Oct 30, 2026Market cap $1.28BP/E –Yield 2.10%
Earnings
U S Physical Therapy's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of U S Physical Therapy's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026after the close | $214.10M | +8.5% | $0.25 | $0.75 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 6, 2026after the close | $198.30M | +7.9% | -$0.12 | $0.46 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025after the close | $197.13M | – | $0.48 | $0.66 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 7, 2025before the open | $197.34M | – | $0.58 | $0.81 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025after the close | $183.79M | – | $0.80 | $0.48 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 28, 2024after the close | $154.80M | +9.6% | -$0.38 | $0.59 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 8, 2023after the close | $150.00M | +7.4% | $0.51 | $0.62 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 9, 2023during market hours | $151.50M | +7.7% | $0.64 | $0.76 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 5, 2023during market hours | $148.50M | +12.8% | $0.58 | $0.59 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 23, 2023during market hours | $141.20M | +8.8% | -$0.01 | $0.58 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 2, 2022after the close | $139.60M | +10.9% | $0.72 | $0.58 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 4, 2022before the open | $140.70M | +10.9% | $0.87 | $0.90 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 5, 2022during market hours | $131.70M | +17.2% | $0.67 | $0.65 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 24, 2022during market hours | $129.80M | +10.5% | $0.73 | $0.72 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 4, 2021during market hours | $125.90M | – | $0.66 | $0.85 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 5, 2021before the open | $126.90M | – | $0.82 | $0.96 | Release |
| Q1 FY2021ended Mar 31, 2021 | May 6, 2021before the open | $112.40M | – | $0.21 | $0.64 | Release |
| Q4 FY2020ended Dec 31, 2020 | Feb 25, 2021before the open | $117.50M | – | $0.68 | $1.08 | Release |
| Q3 FY2020ended Sep 30, 2020 | Nov 5, 2020before the open | – | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 6, 2020before the open | – | – | – | – | Filing |
| Q1 FY2020ended Mar 31, 2020 | May 21, 2020before the open | – | – | – | – | Filing |
| Q4 FY2019ended Dec 31, 2019 | Feb 27, 2020before the open | – | – | – | – | Release |
| Q3 FY2019ended Sep 30, 2019 | Nov 7, 2019before the open | – | – | – | – | Release |
| Q2 FY2019ended Jun 30, 2019 | Aug 8, 2019before the open | – | – | – | – | Filing |
| Q1 FY2019ended Mar 31, 2019 | May 2, 2019before the open | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
U S Physical Therapy's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| adjusted EBITDAnon-GAAP | FY2026 | $102.00M – $106.00M | $102.00M – $106.00M | Reaffirmed | Aug 6, 2026 |
Guidance history
Every forecast U S Physical Therapy put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 6, 2026 | adjusted EBITDA | FY2026 | $102.00M – $106.00M | Reaffirmed |
| May 6, 2026 | adjusted EBITDA | FY2026 | $102.00M – $106.00M | New |
| Nov 6, 2025 | Adjusted EBITDA | FY2025 | $93.00M – $97.00M | Reaffirmed |
| Aug 7, 2025 | Adjusted EBITDA | FY2025 | $93.00M – $97.00M | New |
| Feb 28, 2024 | Adjusted EBITDA | FY2024 | $80.00M – $85.00M | New |
| Nov 7, 2023 | Adjusted EBITDA | FY2023 | $75.00M – $80.00M | Reaffirmed |
| Aug 9, 2023 | Adjusted EBITDA | FY2023 | $75.00M – $80.00M | Reaffirmed |
| May 5, 2023 | Adjusted EBITDA | FY2023 | $75.00M – $80.00M | Reaffirmed |
| Feb 23, 2023 | Adjusted EBITDA | FY2023 | $75.00M – $80.00M | New |
| Nov 2, 2022 | Adjusted EBITDA | FY2022 | $73.50M – $75.40M | Reaffirmed |
| Nov 2, 2022 | Operating Results | FY2022 | $2.65 – $2.75 | Reaffirmed |
| Nov 2, 2022 | Operating Results | FY2022 | $34.40M – $35.80M | Reaffirmed |
| Aug 4, 2022 | Adjusted EBITDA | FY2022 | $73.50M – $75.40M | New |
| Aug 4, 2022 | Operating Results per share | FY2022 | $2.65 – $2.75 | Lowered |
| Aug 4, 2022 | Operating Results | FY2022 | $34.40M – $35.80M | Lowered |
| Feb 24, 2022 | Operating Results per diluted share | FY2022 | $3.25 – $3.35 | New |
| Feb 24, 2022 | Operating Results | FY2022 | $42.20M – $43.50M | New |
| Feb 24, 2022 | estimated annual effective tax rate | FY2022 | 27.1% | New |
| Aug 5, 2021 | Operating Results per diluted share | FY2021 | $3.05 – $3.15 | Raised |
| Aug 5, 2021 | estimated annual effective tax rate | FY2021 | 27% | Reaffirmed |
| Aug 5, 2021 | Operating Results | FY2021 | $39.40M – $40.60M | Raised |
| May 6, 2021 | Operating Results per share | FY2021 | $2.68 – $2.78 | Raised |
| May 6, 2021 | estimated annual effective tax rate | FY2021 | 27% | New |
| May 6, 2021 | Operating Results | FY2021 | $34.50M – $35.80M | Raised |
| Feb 25, 2021 | Operating Results | FY2021 | $2.40 – $2.52 | New |
| Feb 25, 2021 | Operating Results | FY2021 | $30.90M – $32.50M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases U S Physical Therapy filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- Update
- Update
- Results
- News
- Update
- Update
- Results
- Update
- Update
- Update
- News
- News
- News